Heparan sulfate proteoglycans play important biological roles in cell-cell
and cell-matrix adhesion, and are closely associated with growth factor act
ions. Loss of syndecan-1, a cell surface-bound heparan sulfate proteoglycan
, has been reported for advanced head and neck carcinomas, and expression o
f endoglycosidic heparanase, which cleaves heparan sulfate glycosaminoglyca
ns (HS-GAGs), is associated with invasion and metastatic potential of malig
nant tumors. Paraffin sections of 103 primary esophageal squamous cell carc
inomas were immunohistochemically examined for the expression of syndecan-1
core protein, HS-GAGs and heparanase protein, and the results were compare
d with various clinicopathological parameters, such as invasion depth. For
16 cases, fresh tumor samples were quantitatively analyzed for heparanase a
nd syndecan-1 mRNA expression by real-time RT-PCR in addition to the immuno
histochemical studies. Syndecan-1 core protein and HS-GAGs expression was s
ignificantly decreased in pT2 and pT3 cases compared with their pTis and pT
1 counterparts. Decreased expression of core protein and HS-GAGs was correl
ated with the incidence of lymphatic invasion, and venous involvement. Furt
hermore, decreased expression of HS-GAGs was correlated positively with the
incidence of nodal metastasis and distant organ metastasis, and negatively
with the grade of tumor cell differentiation. The percentage of cytoplasmi
c heparanase protein-positive cases increased significantly in pT2 and pT3
cases compared to that in pTis and pT1 cases, and this was associated with
lymphatic invasion, and venous and lymph nodal involvement. The level of he
paranase mRNA was inversely correlated with the degree of HS-GAGs expressio
n rather than core protein. In conclusion, loss of syndecan-1 and heparanas
e overexpression in esophageal squamous cell carcinomas are closely associa
ted with malignant potential. Regarding the mechanism of loss of HS-GAGs, h
eparanase upregulation appears to play an important role.